The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
“The current arrangement will see 30.000 additional shares coming our way each trading day for the next 1,5 years.”
Or a weeks worth of the sort of after hours trade we saw yesterday ….unless you really think Prim are going to divest themselves of their holding by selling 30000 shares a day ….
If you look at our MKT CAP it hasn't really responded yet. Sure, we have had some nice daily rises but they have only been a response to our ridiculous sp (8/9p). we are at a conservative $50 price and the peak in 2018 was $120? so we should be just under half our MKT CAP at that time.
The way I see it BMN want the original deal to happen as it would have had the litigation not delayed it. `there has been an extension on the deal with the terms slightly amended and we have lent them some money to help them out short term
I always found it interesting that we have never attempted to develop it or sell it. You could argue either option would not look good to a 'Green energy ' company. It was acquired as part of the lemur deal , in a sense a by product of it. perhaps its lack of activity is a signal or our intention to let it wither and die on the vine so to speak.Sure, there is an economic cost to that but the repetitional cost to our green credentials could be greater.